-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Reiterates Overweight on Abbott Laboratories, Raises Price Target to $145

Benzinga·04/17/2025 16:47:30
Listen to the news
Piper Sandler analyst Adam Maeder reiterates Abbott Laboratories (NYSE:ABT) with a Overweight and raises the price target from $133 to $145.